Bicara Therapeutics Inc. Common Stock (BCAX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 544.91M | 422.05M | 297.37M | 444.39M | 470.75M | 502.53M | 521.51M | 206.08M | 206.08M | 231.07M | 0 |
| Cash & Short-Term Investments | 539.75M | 414.8M | 290.17M | 436.61M | 462.06M | 489.71M | 520.76M | 203.85M | 203.85M | 230.44M | 4.16M |
| Cash Only | 323.46M | 96.69M | 171.67M | 436.61M | 462.06M | 489.71M | 520.76M | 203.85M | 203.85M | 230.44M | 0 |
| Short-Term Investments | 216.29M | 318.12M | 118.49M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 5.16M | 7.25M | 7.21M | 0 | 8.69M | 12.82M | 0 | 2.22M | 0 | 100K | -4.16M |
| Total Non-Current Assets | 8.68M | 8.94M | 127.32M | 9.2M | 7.32M | 66.66M | 2.66M | 2.71M | 2.71M | 2.91M | 0 |
| Property, Plant & Equipment | 1.77M | 2.03M | 2.1M | 2.35M | 688K | 845K | 544K | 619K | 619K | 815K | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 117.42M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 6.91M | 6.91M | 7.79M | 6.84M | 6.63M | 6.62M | 2.12M | 2.09M | 2.09M | 2.09M | 0 |
| Total Assets | 553.6M | 430.99M | 424.69M | 453.59M | 478.08M | 569.2M | 524.17M | 208.78M | 208.78M | 233.98M | 0 |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 15.8% | -24.28% | -18.98% | 117.25% | 128.98% | 143.26% | - | - | - | - | - |
| Total Current Liabilities | 39.34M | 28.95M | 21.03M | 17.23M | 19.12M | 17.99M | 14.48M | 16.07M | 16.07M | 15.09M | 0 |
| Accounts Payable | 6.19M | 5.51M | 3M | 2.91M | 2.74M | 4.51M | 1.96M | 4.68M | 4.68M | 3.19M | 0 |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 1.14M | 1.12M | 1.09M | 0 | 0 | 607K | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 32.01M | 22.32M | 16.93M | 0 | 1.68M | 9.79M | 0 | 1.12M | 0 | 0 | 0 |
| Current Ratio | 13.85x | 14.58x | 14.14x | 25.80x | 24.62x | 27.93x | 36.01x | 12.83x | 12.83x | 15.32x | - |
| Quick Ratio | 13.85x | 14.58x | 14.14x | 25.80x | 24.62x | 27.93x | 36.01x | 12.83x | 12.83x | 15.32x | - |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 301K | 593K | 880K | 1.16M | 0 | 59.33M | 137K | 367.49M | 217K | 389K | 17.28M |
| Long-Term Debt | 301K | 593K | 880K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 1.16M | 0 | 131K | 137K | 217K | 217K | 372K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 59.2M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 367.28M | 0 | 17K | 17.28M |
| Total Liabilities | 39.64M | 29.54M | 21.91M | 18.39M | 19.12M | 77.32M | 14.62M | 383.56M | 16.28M | 15.47M | 17.28M |
| Total Debt | 1.44M | 1.71M | 1.98M | 2.24M | 591K | 738K | 445K | 517K | 517K | 657K | 0 |
| Net Debt | -322.02M | -94.97M | -169.7M | -434.37M | -461.47M | -488.97M | -520.31M | -203.34M | -203.34M | -229.78M | 0 |
| Debt / Equity | 0.00x | 0.00x | 0.00x | 0.01x | 0.00x | 0.00x | 0.00x | - | 0.00x | 0.00x | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 513.96M | 401.45M | 402.78M | 435.2M | 458.96M | 491.88M | 509.56M | -174.78M | 192.5M | 218.51M | -17.28M |
| Equity Growth % | 11.98% | -18.38% | -20.95% | 349% | 138.42% | 125.11% | - | - | 1214.14% | - | - |
| Book Value per Share | 8.46 | 7.28 | 7.38 | 7.98 | 8.43 | 9.04 | 9.37 | -3.23 | 3.55 | 4.12 | -0.32 |
| Total Shareholders' Equity | 513.96M | 401.45M | 402.78M | 435.2M | 458.96M | 491.88M | 509.56M | -174.78M | 192.5M | 218.51M | -17.28M |
| Common Stock | 8K | 0 | 7K | 7K | 7K | 7K | 7K | 2K | 2K | 2K | 0 |
| Retained Earnings | -415.18M | 0 | -321.58M | -285.25M | -257.86M | -221.02M | -200.06M | -182.58M | -182.58M | -153.02M | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -243K | 0 | -136K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -98.8M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |